冠捷科技(000727.SZ):暫未擴展至人腦工程
格隆匯6月1日丨有投資者在投資者互動平台向冠捷科技(000727.SZ)提問,“請問貴司的智慧交通,智慧醫療等相關產品是否能擴展至人腦工程?貴司三千多人的研發團隊只侷限於低端顯示器製造,是不是有點浪費人才?”
公司回覆稱,公司致力於提供全行業、全場景、全尺寸的視訊解決方案,公司生產的顯示產品可廣泛應用於智慧能源、智慧教育、智慧辦公、智慧零售、智慧家居、智慧交通、智慧城市、智慧醫療等多個行業,暫未擴展至人腦工程。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.